Bryan David Bryson

Biography

Publications

• Validation and quantification of peptide antigens presented on MHCs using SureQuant.

  Leddy O, Cui Y, Ahn R, Stopfer L, Choe E, Kim DH, Roerden M, Spranger S, Bryson BD, White FM. Nat Protoc 2024 Oct 22

• Antibody-Fab and -Fc features promote Mycobacterium tuberculosis restriction.

  Grace PS, Peters JM, Sixsmith J, Lu R, Luedeman C, Fenderson BA, Vickers A, Slein MD, Irvine EB, McKitrick T, Wei MH, Cummings RD, Wallace A, Cavacini LA, Choudhary A, Proulx MK, Sundling C, Källenius G, Reljic R, Ernst JD, Casadevall A, Locht C, Pinter A, Sasseti CM, Bryson BD, Fortune SM, Alter G. bioRxiv 2024 Oct 11

• Scalable, compressed phenotypic screening using pooled perturbations.

  Liu N, Kattan WE, Mead BE, Kummerlowe C, Cheng T, Ingabire S, Cheah JH, Soule CK, Vrcic A, McIninch JK, Triana S, Guzman M, Dao TT, Peters JM, Lowder KE, Crawford L, Amini AP, Blainey PC, Hahn WC, Cleary B, Bryson B, Winter PS, Raghavan S, Shalek AK. Nat Biotechnol 2024 Oct 07

• PathMHC: a workflow to selectively target pathogen-derived MHC peptides in discovery immunopeptidomics experiments for vaccine target identification.

  Leddy O, Yuki Y, Carrington M, Bryson BD, White FM. bioRxiv 2024 Sep 11

• Proximity labeling defines the phagosome lumen proteome of murine and primary human macrophages.

  Allsup BL, Gharpure S, Bryson BD. bioRxiv 2024 Sep 08